Replies to post #389665 on Elite Pharmaceuticals Inc (ELTP)

[Pharma Sleuth]

Yep. We have reached critical mass. We are not beholden to waiting on one or two items with unknown time frames.

[The ELTP King]

Big delay on Vigabatrin.

Will provide an update later on today.

Legal issues.

Hopefully Vigabatrin launch soon?

[jour_trader]

Agreed, with mid-November Q2 fiscal results release and hopefully generic OxyContin news around time of antimetabolite approval. Will be good next 6 months. I’m eager to hear how R&D pipeline is getting replenished, upcoming filings (excl gen Vyvanse). I expect generic Concerta to be on deck for bioequivalency w/ filing 1H 2024. After this is filed, we don’t have ton of insight into next big opportunities.